Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Absorbable hemostatic agents.

Michael Gabay1

  • 1College of Pharmacy, University of Illinois Medical Center at Chicago, 833 South Wood Street, M/C 886, Chicago, IL 60612, USA. mgabay@uic.edu

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|June 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FAST Generics Act of 2015.

Hospital pharmacy·2024
Same author

Drug Prices: Is There a Need for Transparency?

Hospital pharmacy·2024
Same author

RxLegal: Emergency Use Authorizations.

Hospital pharmacy·2023
Same author

Transdermal Patch Administration and Magnetic Resonance Imaging (MRI)-2020.

Hospital pharmacy·2022
Same author

RxLegal: The Evolving Legal Landscape of Telehealth.

Hospital pharmacy·2021
Same author

Report on 2020 Safe to Touch Consensus Conference on Hazardous Drug Surface Contamination.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021
Same journal

Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Impact of pharmacist involvement on hospital sepsis response teams.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Attributes of centralized health-system specialty pharmacy clinics: A scoping review using the Donabedian model.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Zoliflodacin: A novel single-dose oral antibiotic for uncomplicated urogenital gonorrhea.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Implementation of a paid apprenticeship-model pharmacy technician training program.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Iodixanol-induced acute generalized exanthematous pustulosis: Cross-reactivity to other iodinated contrast media.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
See all related articles

Absorbable hemostatic agents aid surgical bleeding control when standard methods fail. While generally safe, rare severe adverse effects necessitate careful administration to ensure patient safety.

Area of Science:

  • Surgical hemostasis
  • Pharmacology of hemostatic agents

Background:

  • Absorbable hemostatic agents (AHAs) are used in surgery.
  • They function at various points in the coagulation cascade.
  • AHAs are indicated when conventional methods fail to control bleeding.

Purpose of the Study:

  • Review pharmacology of AHAs.
  • Evaluate clinical efficacy and safety.
  • Examine adverse effects, toxicities, and drug interactions.

Main Methods:

  • Literature review of pharmacology, clinical trials, and case reports.
  • Analysis of efficacy in controlling surgical bleeding.
  • Assessment of reported adverse events and safety concerns.

Main Results:

Related Experiment Videos

  • AHAs are effective as adjunctive therapy for capillary bleeding, vascular surgery, and fistula-puncture sites.
  • Limited direct comparative trials exist; case reports show efficacy, especially for off-label thrombin use.
  • Rare but severe adverse effects (e.g., paralysis) have been reported.

Conclusions:

  • AHAs are valuable adjuncts in surgical bleeding management.
  • Careful administration is crucial to mitigate rare but severe adverse effects.
  • Further research may clarify optimal dosing and comparative efficacy.